Clinical Trial Update: Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®

View source ↗

Summary

Non-interventional study in open-angle glaucoma and/or ocular hypertension treated with XALATAN (latanoprost) completed; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Ocular Hypertension

Drugs mentioned

• Xalatan (latanoprost)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Glaucoma,Open-Angle, Ocular Hypertension | Status: COMPLETED | Results posted: 2009-07-16